Protagonist Therapeutics Inc Conference Call to Discuss its Agreement with Janssen Biotech, Inc to Co-Develop and Commercialize

30/5/2017 8:00

Conference Call Protagonist Therapeutics Inc

Protagonist Therapeutics Inc Conference call or earnings call will be held on May 30, 2017
During the earnings conference call’s session, Protagonist Therapeutics Inc will provide updated information and financial performance report status.
In order to join the earning call, dial the conference’s bridge and key in the PIN code. Contact Protagonist Therapeutics Inc for this information
More and more companies choose to conduct their earnings calls through conference calls and online meetings and it’s important to keep up to date with all relevant information.
Need a conference calls service solution? Try QCONF conferencing today, Sign up now and get 5 free conference calls (no credit card required)
Is this is your first earnings call? Check out Nasdaq guide for how to read an earnings report?
We are a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities ("NCEs" ) to address significant unmet medical needs. Our primary focus is on developing first-in-class oral peptide drugs that specifically target the same biological pathways also targeted by currently marketed injectable antibody drugs. Compared to injectable antibody drugs, our oral peptides offer targeted delivery to the gastrointestinal ("GI") tissue compartment, potential for improved safety due to minimal exposure in the blood, improved convenience and compliance due to oral delivery and the opportunity for earlier introduction of targeted therapy for inflammatory bowel disease ("IBD").    
Read more Conference Call

Protagonist Therapeutics Inc (PTGX)

521 Cottonwood Drive, Milpitas California 95035, United States